시장보고서
상품코드
1838767

겸상 적혈구증(SCD) 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 용도별, 디바이스별, 프로세스별, 최종 사용자별, 기능별(-2034년)

Sickle Cell Disease Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, Device, Process, End User, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 357 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

겸상 적혈구증 시장은 2024년 49억 달러에서 2034년 207억 달러로 확대될 것으로 예측되며, 약 15.5%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다. 겸상 적혈구증 시장에는 유전성 혈액 질환인 겸상 적혈구 빈혈의 관리 및 치료를 위한 치료 솔루션과 서비스가 포함됩니다. 이 시장에는 의약품, 유전자 치료제 및 지원 요법 제품이 포함됩니다. 인지도의 향상, 유전자 편집 기술의 진보, 의료 투자 증가가 시장 성장을 가속하고 있습니다. 주요 기업은 환자의 결과 및 삶의 질을 개선하는 혁신적인 치료에 주력하고 있습니다.

겸상 적혈구증 시장은 치료 옵션의 진보 및 인지도 향상에 힘입어 큰 성장을 이루고 있습니다. 의약품 부문이 최고이며 유전자 치료와 CRISPR 기술이 치유 솔루션을 제공할 수 있기 때문입니다. 히드록시우레아 요법과 L-글루타민 요법은 여전히 중요하며, 증상의 완화와 환자의 QOL 향상을 가져옵니다. 진단학 분야는 조기 발견과 비침습적 검사 기술의 혁신에 견인되어 두 번째로 높은 실적을 올리고 있습니다. 포인트 오브 케어 검사 기기가 인기를 끌고 있으며, 적시 개입 및 관리를 용이하게 하고 있습니다. 맞춤형 의료가 중시되고, 맞춤형 치료 접근법에 대한 수요가 더욱 높아지고 있습니다. 바이오 의약품의 연구개발 투자는 미충족 요구에 대응하고 치료 효과를 향상시키기 위해 가속화되고 있습니다. 원격 의료 및 모바일 헬스 애플리케이션과 같은 디지털 헬스 툴의 통합은 원격 모니터링 및 지원을 제공하고 환자 관리에 변화를 가져오고 있습니다. 이러한 진보는 겸상 적혈구증을 둘러싼 상황에서 유리한 비즈니스 기회를 약속합니다.

시장 세분화
유형별 겸상 적혈구 빈혈, 겸상 베타 살라세미아, 겸상 헤모글로빈 C병
제품별 의약품, 수혈 제품, 유전자 치료 제품, 통증 관리 약물, 히드록시우레아, L-글루타민, 복셀로톨, 크리잔 리즈맙
서비스별 환자 상담, 유전 상담, 진단 서비스, 원격 의료
기술별 유전자 편집, CRISPR, RNA 간섭, 줄기 세포 치료
용도별 질병 관리, 조사, 진단, 치료
디바이스별 진단 기기, 모니터링 기기
프로세스별 수혈, 골수 이식
최종 사용자별 병원, 전문 클리닉, 연구 기관, 제약 회사
기능별 통증 관리, 빈혈 관리, 장기 장애 예방

시장 현황

겸상 적혈구증 시장은 새로운 치료제와 혁신적인 치료법의 도입으로 시장 점유율이 좌우되는 등 큰 변화를 맞이하고 있습니다. 효능과 환자 결과 향상을 약속하는 첨단 제품의 출시로 가격 전략은 점점 더 경쟁력을 늘리고 있습니다. 제약회사는 새로운 솔루션을 시장에 투입하기 위해 연구개발에 적극적으로 투자하고 있어 경쟁 구도가 변화하고 있습니다. 이 역동적인 환경은 급속한 진보를 촉진하고 이해 관계자에게 유리한 기회를 제공합니다. 경쟁 벤치마킹에서 주요 기업은 전략적 제휴 및 인수를 통해 차별화를 도모하고 시장에서의 지위를 강화하고 있습니다. 규제의 영향은 매우 중요한 역할을 하고 있으며, 북미와 유럽의 엄격한 승인 프로세스가 시장 진입과 확대에 영향을 미치고 있습니다. 이 시장 특징은 임상시험에 대한 왕성한 투자 및 맞춤형 의료 중시의 고조입니다. 이러한 요인은 규제 상황과 결합하여 겸상 적혈구증 시장의 궤도를 형성하고 있으며 분석 및 전략 입안을 위한 종합적인 전망을 제공합니다.

주요 동향 및 성장 촉진요인

겸상 적혈구증(SCD) 시장은 유전자 치료 및 맞춤형 의료의 진보에 따라 변화적인 성장을 이루고 있습니다. 주요 동향으로는 CRISPR을 이용한 치료법의 개발과 뿌리 치료법에 대한 주목의 향상이 있습니다. 이러한 혁신은 SCD의 근본 원인을 다루며 대증 치료에 머무르지 않는 장기적인 해결책을 제공할 것으로 기대됩니다. 제약회사는 이러한 첨단 치료법을 시장에 투입하기 위해 연구개발에 많은 투자를 하고 있습니다. 또 다른 원동력은 특히 유병률이 높은 지역에서 SCD에 대한 인식과 진단이 높아지고 있다는 것입니다. 이러한 인식을 통해 조기 개입과 더 나은 관리가 이루어지고 있습니다. 또한 정부와 비영리 단체가 연구 자금을 제공하고 새로운 치료법에 대한 환자 접근을 지원함으로써 중요한 역할을 수행하고 있습니다. 원격 의료 및 디지털 헬스 플랫폼에도 비즈니스 기회가 탄생하고 있으며 환자 모니터링 및 참여도를 강화하고 있습니다. 이러한 기술이 진화함에 따라, SCD 시장에서 환자 결과의 개선 및 헬스케어 제공의 간소화가 기대됩니다.

성장 억제요인 및 과제 :

겸상 적혈구증 시장에는 몇 가지 현저한 억제요인 및 과제가 있습니다. 큰 억제요인으로는 신규 치료제의 높은 비용, 저소득 지역의 환자에게는 이용하기 어려운 것을 들 수 있습니다. 많은 헬스케어 시스템은 이러한 비용의 흡수에 고민하고 있으며, 치료 가능성의 격차로 이어지고 있습니다. 또한 특정 지역에서는 겸상 적혈구증에 대한 인식과 교육이 부족하기 때문에 조기 진단 및 조기 개입을 방해합니다. 이 시장은 또한 임상시험의 복잡성으로 인한 과제에 직면하고 있습니다. 임상시험 참가자의 모집 및 확보가 어려워, 새로운 치료법의 개발에 영향을 주고 있습니다. 게다가, 겸상 적혈구증 관리에 대해 훈련받은 헬스케어 전문가가 부족하여 환자 결과에 영향을 미칩니다. 새로운 치료법의 승인 과정에는 시간과 비용이 많이 들고, 규제 상의 장애물도 과제가 되고 있습니다. 마지막으로, 스티그마와 차별과 같은 사회 경제적 요인은 환자의 치료에 대한 접근을 더욱 복잡하게 만듭니다. 이러한 과제는 총체적으로 겸상 적혈구증 시장의 진전을 방해하고 있습니다.

주요 기업

Global Blood Therapeutics, Emmaus Life Sciences, Agios Pharmaceuticals, Novartis Gene Therapies, Bluebird Bio, Sangamo Therapeutics, CRISPR Therapeutics, Editas Medicine, Graphite Bio, Beam Therapeutics, Imara Inc, Protagonist Therapeutics, Fate Therapeutics, ArcherDX, Rocket Pharmaceuticals

목차

제1장 겸상 적혈구증 시장 개요

  • 조사 목적
  • 겸상 적혈구증 시장 정의 및 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 겸상 적혈구증 시장 전망

  • 겸상 적혈구증 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 겸상 적혈구증 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 겸상 적혈구증 시장 규모

  • 겸상 적혈구증 시장 규모 : 금액별
  • 겸상 적혈구증 시장 규모 : 수량별

제7장 겸상 적혈구증 시장 : 유형별

  • 시장 개요
  • 겸상 적혈구 빈혈
  • 겸상 β 살라세미아
  • 겸상 헤모글로빈 C병
  • 기타

제8장 겸상 적혈구증 시장 : 제품별

  • 시장 개요
  • 의약품
  • 수혈 제품
  • 유전자 치료제
  • 통증 관리 약
  • 히드록시우레아
  • L-글루타민
  • 복셀로톨
  • 크리잔 리즈맙
  • 기타

제9장 겸상 적혈구증 시장 : 서비스별

  • 시장 개요
  • 환자 상담
  • 유전 상담
  • 진단 서비스
  • 원격 의료
  • 기타

제10장 겸상 적혈구증 시장 : 기술별

  • 시장 개요
  • 유전자 편집
  • CRISPR
  • RNA 간섭
  • 줄기세포 치료
  • 기타

제11장 겸상 적혈구증 시장 : 용도별

  • 시장 개요
  • 질병 관리
  • 조사
  • 진단
  • 치료
  • 기타

제12장 겸상 적혈구증 시장 : 디바이스별

  • 시장 개요
  • 진단 기기
  • 모니터링 기기
  • 기타

제13장 겸상 적혈구증 시장 : 프로세스별

  • 시장 개요
  • 수혈
  • 골수 이식
  • 기타

제14장 겸상 적혈구증 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 전문 클리닉
  • 연구기관
  • 제약회사
  • 기타

제15장 겸상 적혈구증 시장 : 기능별

  • 시장 개요
  • 통증 관리
  • 빈혈 관리
  • 장기장애 예방
  • 기타

제16장 겸상 적혈구증 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제18장 기업 프로파일

  • Global Blood Therapeutics
  • Emmaus Life Sciences
  • Agios Pharmaceuticals
  • Novartis Gene Therapies
  • Bluebird Bio
  • Sangamo Therapeutics
  • CRISPR Therapeutics
  • Editas Medicine
  • Graphite Bio
  • Beam Therapeutics
  • Imara Inc
  • Protagonist Therapeutics
  • Fate Therapeutics
  • ArcherDX
  • Rocket Pharmaceuticals
AJY 25.11.14

Sickle Cell Disease Market is anticipated to expand from $4.9 billion in 2024 to $20.7 billion by 2034, growing at a CAGR of approximately 15.5%. The Sickle Cell Disease Market encompasses therapeutic solutions and services aimed at managing and treating sickle cell anemia, a genetic blood disorder. This market includes pharmaceuticals, gene therapies, and supportive care products. Increasing awareness, advancements in gene editing technologies, and rising healthcare investments are propelling market growth. Key players focus on innovative treatments to improve patient outcomes and quality of life.

The Sickle Cell Disease Market is experiencing significant growth, fueled by advancements in treatment options and increased awareness. The pharmaceutical segment is the top performer, with gene therapy and CRISPR technology leading due to their potential to offer curative solutions. Hydroxyurea and L-glutamine therapies remain critical, providing symptomatic relief and improving patient quality of life. The diagnostics segment is the second-highest performer, driven by innovations in early detection and non-invasive testing techniques. Point-of-care testing devices are gaining popularity, facilitating timely intervention and management. The growing emphasis on personalized medicine further boosts the demand for tailored therapeutic approaches. Biopharmaceutical investments in R&D are accelerating, aiming to address unmet needs and enhance treatment efficacy. The integration of digital health tools, such as telemedicine and mobile health applications, is transforming patient care, offering remote monitoring and support. These advancements collectively promise lucrative opportunities within the sickle cell disease landscape.

Market Segmentation
TypeSickle Cell Anemia, Sickle Beta Thalassemia, Sickle Hemoglobin-C Disease
ProductPharmaceuticals, Blood Transfusion Products, Gene Therapy Products, Pain Management Drugs, Hydroxyurea, L-Glutamine, Voxelotor, Crizanlizumab
ServicesPatient Counseling, Genetic Counseling, Diagnostic Services, Telemedicine
TechnologyGene Editing, CRISPR, RNA Interference, Stem Cell Therapy
ApplicationDisease Management, Research, Diagnosis, Treatment
DeviceDiagnostic Devices, Monitoring Devices
ProcessBlood Transfusion, Bone Marrow Transplantation
End UserHospitals, Specialty Clinics, Research Institutes, Pharmaceutical Companies
FunctionalityPain Management, Anemia Management, Organ Damage Prevention

Market Snapshot:

The Sickle Cell Disease Market is witnessing significant shifts, with market share being influenced by the introduction of novel therapeutics and innovative treatment modalities. Pricing strategies are becoming increasingly competitive, driven by the launch of advanced products that promise enhanced efficacy and patient outcomes. Pharmaceutical companies are actively investing in research and development to bring new solutions to the market, thereby altering the competitive landscape. This dynamic environment is fostering rapid advancements and offering lucrative opportunities for stakeholders. In terms of competition benchmarking, key players are differentiating themselves through strategic collaborations and acquisitions to bolster their market positions. Regulatory influences play a pivotal role, with stringent approval processes in North America and Europe impacting market entry and expansion. The market is characterized by robust investment in clinical trials and a growing emphasis on personalized medicine. These factors, combined with regulatory frameworks, are shaping the trajectory of the Sickle Cell Disease Market, offering a comprehensive landscape for analysis and strategic planning.

Geographical Overview:

The Sickle Cell Disease market is witnessing varied growth patterns across global regions. North America remains at the forefront, driven by advanced healthcare infrastructure and substantial research funding. The presence of leading pharmaceutical companies enhances market dynamics, fostering innovation in treatment options. Europe follows, with a strong emphasis on research collaborations and governmental support for rare disease management. This region benefits from a robust regulatory framework that accelerates drug approvals. In Asia Pacific, the market is expanding swiftly due to increasing awareness and improving healthcare access. Countries like India and China are emerging as key growth pockets, driven by large patient populations and rising investments in healthcare. Latin America is also gaining momentum, with Brazil and Mexico investing in healthcare reforms to address sickle cell disease. Meanwhile, the Middle East & Africa are recognizing the importance of tackling genetic disorders, with countries like Nigeria and South Africa prioritizing healthcare initiatives and research funding.

Key Trends and Drivers:

The Sickle Cell Disease (SCD) market is experiencing transformative growth driven by advancements in gene therapy and personalized medicine. Key trends include the development of CRISPR-based treatments and the increasing focus on curative therapies. These innovations promise to address the root cause of SCD, offering long-term solutions beyond symptomatic relief. Pharmaceutical companies are investing heavily in research and development to bring these cutting-edge therapies to market. Another driver is the growing awareness and diagnosis of SCD, particularly in regions with high prevalence. This awareness is leading to earlier interventions and better management of the disease. Additionally, government and non-profit organizations are playing a crucial role by funding research and supporting patient access to emerging treatments. Opportunities are also emerging in telemedicine and digital health platforms, which are enhancing patient monitoring and engagement. As these technologies evolve, they are expected to improve patient outcomes and streamline healthcare delivery in the SCD market.

Restraints and Challenges:

The Sickle Cell Disease market encounters several prominent restraints and challenges. A significant restraint is the high cost of novel therapies, which limits accessibility for patients in low-income regions. Many healthcare systems struggle to absorb these costs, leading to disparities in treatment availability. Furthermore, the lack of awareness and education about sickle cell disease in certain areas hampers early diagnosis and intervention. The market also faces challenges due to the complexity of clinical trials. Recruiting and retaining participants for trials is difficult, impacting the development of new therapies. Additionally, there is a shortage of healthcare professionals trained in managing sickle cell disease, which affects patient outcomes. Regulatory hurdles also pose a challenge, as navigating the approval process for new treatments is often time-consuming and costly. Lastly, socio-economic factors, such as stigma and discrimination, further complicate patient access to care. These challenges collectively impede progress in the sickle cell disease market.

Key Players:

Global Blood Therapeutics, Emmaus Life Sciences, Agios Pharmaceuticals, Novartis Gene Therapies, Bluebird Bio, Sangamo Therapeutics, CRISPR Therapeutics, Editas Medicine, Graphite Bio, Beam Therapeutics, Imara Inc, Protagonist Therapeutics, Fate Therapeutics, ArcherDX, Rocket Pharmaceuticals

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Sickle Cell Disease Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Sickle Cell Disease Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by Device
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by End User
  • 2.11 Key Highlights of the Market, by Functionality
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by Device
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by End User
  • 3.10 Market Attractiveness Analysis, by Functionality
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Sickle Cell Disease Market Outlook

  • 4.1 Sickle Cell Disease Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Sickle Cell Disease Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Sickle Cell Disease Market Size

  • 6.1 Sickle Cell Disease Market Size, by Value
  • 6.2 Sickle Cell Disease Market Size, by Volume

7: Sickle Cell Disease Market, by Type

  • 7.1 Market Overview
  • 7.2 Sickle Cell Anemia
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Sickle Beta Thalassemia
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Sickle Hemoglobin-C Disease
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Sickle Cell Disease Market, by Product

  • 8.1 Market Overview
  • 8.2 Pharmaceuticals
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Blood Transfusion Products
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Gene Therapy Products
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Pain Management Drugs
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Hydroxyurea
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 L-Glutamine
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Voxelotor
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Crizanlizumab
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Sickle Cell Disease Market, by Services

  • 9.1 Market Overview
  • 9.2 Patient Counseling
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Genetic Counseling
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Diagnostic Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Telemedicine
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Sickle Cell Disease Market, by Technology

  • 10.1 Market Overview
  • 10.2 Gene Editing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 CRISPR
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 RNA Interference
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Stem Cell Therapy
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Sickle Cell Disease Market, by Application

  • 11.1 Market Overview
  • 11.2 Disease Management
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Research
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Diagnosis
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Treatment
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Sickle Cell Disease Market, by Device

  • 12.1 Market Overview
  • 12.2 Diagnostic Devices
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Monitoring Devices
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Sickle Cell Disease Market, by Process

  • 13.1 Market Overview
  • 13.2 Blood Transfusion
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Bone Marrow Transplantation
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Sickle Cell Disease Market, by End User

  • 14.1 Market Overview
  • 14.2 Hospitals
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Specialty Clinics
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Research Institutes
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Pharmaceutical Companies
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Sickle Cell Disease Market, by Functionality

  • 15.1 Market Overview
  • 15.2 Pain Management
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Anemia Management
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Organ Damage Prevention
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Sickle Cell Disease Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by Device
    • 16.2.8 North America Market Size and Forecast, by Process
    • 16.2.9 North America Market Size and Forecast, by End User
    • 16.2.10 North America Market Size and Forecast, by Functionality
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by Device
      • 16.2.9.7 United States Market Size and Forecast, by Process
      • 16.2.9.8 United States Market Size and Forecast, by End User
      • 16.2.9.9 United States Market Size and Forecast, by Functionality
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by Device
      • 16.2.10.7 Canada Market Size and Forecast, by Process
      • 16.2.10.8 Canada Market Size and Forecast, by End User
      • 16.2.10.9 Canada Market Size and Forecast, by Functionality
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by Device
    • 16.3.8 Europe Market Size and Forecast, by Process
    • 16.3.9 Europe Market Size and Forecast, by End User
    • 16.3.10 Europe Market Size and Forecast, by Functionality
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.8 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Functionality
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by Device
      • 16.3.10.7 Germany Market Size and Forecast, by Process
      • 16.3.10.8 Germany Market Size and Forecast, by End User
      • 16.3.10.9 Germany Market Size and Forecast, by Functionality
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by Device
      • 16.3.11.7 France Market Size and Forecast, by Process
      • 16.3.11.8 France Market Size and Forecast, by End User
      • 16.3.11.9 France Market Size and Forecast, by Functionality
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by Device
      • 16.3.12.7 Spain Market Size and Forecast, by Process
      • 16.3.12.8 Spain Market Size and Forecast, by End User
      • 16.3.12.9 Spain Market Size and Forecast, by Functionality
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by Device
      • 16.3.13.7 Italy Market Size and Forecast, by Process
      • 16.3.13.8 Italy Market Size and Forecast, by End User
      • 16.3.13.9 Italy Market Size and Forecast, by Functionality
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by Device
      • 16.3.14.7 Netherlands Market Size and Forecast, by Process
      • 16.3.14.8 Netherlands Market Size and Forecast, by End User
      • 16.3.14.9 Netherlands Market Size and Forecast, by Functionality
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by Device
      • 16.3.15.7 Sweden Market Size and Forecast, by Process
      • 16.3.15.8 Sweden Market Size and Forecast, by End User
      • 16.3.15.9 Sweden Market Size and Forecast, by Functionality
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by Device
      • 16.3.16.7 Switzerland Market Size and Forecast, by Process
      • 16.3.16.8 Switzerland Market Size and Forecast, by End User
      • 16.3.16.9 Switzerland Market Size and Forecast, by Functionality
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by Device
      • 16.3.17.7 Denmark Market Size and Forecast, by Process
      • 16.3.17.8 Denmark Market Size and Forecast, by End User
      • 16.3.17.9 Denmark Market Size and Forecast, by Functionality
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by Device
      • 16.3.18.7 Finland Market Size and Forecast, by Process
      • 16.3.18.8 Finland Market Size and Forecast, by End User
      • 16.3.18.9 Finland Market Size and Forecast, by Functionality
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by Device
      • 16.3.19.7 Russia Market Size and Forecast, by Process
      • 16.3.19.8 Russia Market Size and Forecast, by End User
      • 16.3.19.9 Russia Market Size and Forecast, by Functionality
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Functionality
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.9 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by Device
      • 16.4.9.7 China Market Size and Forecast, by Process
      • 16.4.9.8 China Market Size and Forecast, by End User
      • 16.4.9.9 China Market Size and Forecast, by Functionality
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by Device
      • 16.4.10.7 India Market Size and Forecast, by Process
      • 16.4.10.8 India Market Size and Forecast, by End User
      • 16.4.10.9 India Market Size and Forecast, by Functionality
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by Device
      • 16.4.11.7 Japan Market Size and Forecast, by Process
      • 16.4.11.8 Japan Market Size and Forecast, by End User
      • 16.4.11.9 Japan Market Size and Forecast, by Functionality
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by Device
      • 16.4.12.7 South Korea Market Size and Forecast, by Process
      • 16.4.12.8 South Korea Market Size and Forecast, by End User
      • 16.4.12.9 South Korea Market Size and Forecast, by Functionality
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by Device
      • 16.4.13.7 Australia Market Size and Forecast, by Process
      • 16.4.13.8 Australia Market Size and Forecast, by End User
      • 16.4.13.9 Australia Market Size and Forecast, by Functionality
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by Device
      • 16.4.14.7 Singapore Market Size and Forecast, by Process
      • 16.4.14.8 Singapore Market Size and Forecast, by End User
      • 16.4.14.9 Singapore Market Size and Forecast, by Functionality
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by Device
      • 16.4.15.7 Indonesia Market Size and Forecast, by Process
      • 16.4.15.8 Indonesia Market Size and Forecast, by End User
      • 16.4.15.9 Indonesia Market Size and Forecast, by Functionality
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by Device
      • 16.4.16.7 Taiwan Market Size and Forecast, by Process
      • 16.4.16.8 Taiwan Market Size and Forecast, by End User
      • 16.4.16.9 Taiwan Market Size and Forecast, by Functionality
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by Device
      • 16.4.17.7 Malaysia Market Size and Forecast, by Process
      • 16.4.17.8 Malaysia Market Size and Forecast, by End User
      • 16.4.17.9 Malaysia Market Size and Forecast, by Functionality
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by Device
    • 16.5.8 Latin America Market Size and Forecast, by Process
    • 16.5.9 Latin America Market Size and Forecast, by End User
    • 16.5.10 Latin America Market Size and Forecast, by Functionality
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by Device
      • 16.5.9.7 Brazil Market Size and Forecast, by Process
      • 16.5.9.8 Brazil Market Size and Forecast, by End User
      • 16.5.9.9 Brazil Market Size and Forecast, by Functionality
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by Device
      • 16.5.10.7 Mexico Market Size and Forecast, by Process
      • 16.5.10.8 Mexico Market Size and Forecast, by End User
      • 16.5.10.9 Mexico Market Size and Forecast, by Functionality
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by Device
      • 16.5.11.7 Argentina Market Size and Forecast, by Process
      • 16.5.11.8 Argentina Market Size and Forecast, by End User
      • 16.5.11.9 Argentina Market Size and Forecast, by Functionality
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Functionality
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.9 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Functionality
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Functionality
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by Device
      • 16.6.10.7 UAE Market Size and Forecast, by Process
      • 16.6.10.8 UAE Market Size and Forecast, by End User
      • 16.6.10.9 UAE Market Size and Forecast, by Functionality
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by Device
      • 16.6.11.7 South Africa Market Size and Forecast, by Process
      • 16.6.11.8 South Africa Market Size and Forecast, by End User
      • 16.6.11.9 South Africa Market Size and Forecast, by Functionality
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Functionality
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Global Blood Therapeutics
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Emmaus Life Sciences
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Agios Pharmaceuticals
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Novartis Gene Therapies
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Bluebird Bio
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Sangamo Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 CRISPR Therapeutics
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Editas Medicine
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Graphite Bio
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Beam Therapeutics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Imara Inc
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Protagonist Therapeutics
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Fate Therapeutics
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 ArcherDX
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Rocket Pharmaceuticals
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제